WS #11595
Holding: newest synthesis is 138d 6h old
Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.
Vertex Acquires Crinetics Pharmaceuticals
Vertex Pharmaceuticals agreed to acquire Crinetics for $85/share (~$10B), sending CRNX up ~99% and highlighting M&A in biotech.